Ischemic stroke associated with adenomyosis with marked elevation of serum CA125 level
article
OA: closed
CC0
⤵ 2 in-corpus citations
AI-generated summary
This case report describes a 51-year-old woman with adenomyosis who experienced an ischemic stroke associated with markedly elevated CA125 levels and fibrin degradation products, which resolved with anticoagulation and hormonal therapy.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
Abstract A 51‐year‐old woman with adenomyosis developed vertigo during menstruation. Brain MRI demonstrated acute multiple infarcts. Blood tests showed marked elevation of fibrin degradation products (428.8 μg/mL, reference range: <5.0 μg/mL) and CA125 (4276.7 U/mL, reference range: <35.0 U/mL). Whole‐body CT using contrast medium demonstrated a uterine mass, which was not accompanied by deep vein thrombosis, pulmonary thromboembolism, cardioaortic abnormalities, or cancer. Pelvic MRI demonstrated thickening of the posterior myometrium, consistent with the finding of adenomyosis. Anticoagulation therapy and hormonal therapy for adenomyosis prevented recurrence of ischemic stroke. Our case suggests that serum CA125 level can exceed 100 times the upper reference limit even in patients with adenomyosis and that adenomyosis with marked elevation of serum CA125 causes ischemic stroke.
My notes (saved in your browser only)
Condition tags
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cites (2)
- Usefulness of CA125 in the differential diagnosis of uterine adenomyosis and myoma 2014
- Cerebral infarcts associated with adenomyosis: a rare risk factor for stroke in middle-aged women: a case series 2018
Cited by (2)
References (3)
Cited by (2)
Source provenance
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0
· commercial use OK